Cargando…
Population pharmacokinetics of sirolimus in pediatric patients with kaposiform hemangioendothelioma: A retrospective study
Numerous studies have established population pharmacokinetics (PPK) models of sirolimus in various populations. However, a PPK model of sirolimus in Chinese patients with pediatric kaposiform hemangioendothelioma (PKHE) has yet to be established; therefore, this was the purpose of the present study....
Autores principales: | Wang, Dongdong, Chen, Xiao, Li, Zhiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676569/ https://www.ncbi.nlm.nih.gov/pubmed/31452734 http://dx.doi.org/10.3892/ol.2019.10562 |
Ejemplares similares
-
Pancreatic Kaposiform Hemangioendothelioma Not Responding to Sirolimus
por: Triana, Paloma Junco, et al.
Publicado: (2017) -
Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon
por: Alaqeel, Alaa M., et al.
Publicado: (2016) -
Sirolimus for Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Neonate
por: Cabrera, Trevor B., et al.
Publicado: (2020) -
Management of pancreatic kaposiform hemangioendothelioma with sirolimus in a pediatric patient: a case report and literature review
por: Liang, Zijian, et al.
Publicado: (2022) -
Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences
por: Ji, Yi, et al.
Publicado: (2019)